RT Journal Article
SR Electronic
A1 Sylvester, Bruce
T1 PCI is a “Reasonable” Strategy for Diabetic Patients with Multivessel Disease: The CARDia Trial
JF MD Conference Express
YR 2008
FD SAGE Publications
VO 8
IS 6
SP 19
OP 20
DO 10.1177/155989770800800610
UL http://mdc.sagepub.com/content/8/6/19.abstract
AB At 1 year following intervention, there apparently is no difference between coronary artery bypass grafting and percutaneous coronary intervention in treating diabetic patients with multivessel disease, as measured by the incidence of a composite of death, myocardial infarction, and stroke. These results are part of the Coronary Artery Revascularization in Diabetes [CARDia; ISRCTN19872154] trial.